K31.A0
Gastric intestinal metaplasia, unspecified
Clinical Classification Guidelines
Inclusion Terms
- Gastric intestinal metaplasia indefinite for dysplasia
- Gastric intestinal metaplasia NOS
Medical Intelligence & Overview
Gastric intestinal metaplasia is a condition where the stomach lining begins to change and develop features similar to the intestines. It is considered a pre-cancerous lesion, meaning it can, over time, increase the risk of developing stomach cancer. This condition is often detected during medical examinations and biopsies. Although it does not always cause symptoms, understanding gastric intestinal metaplasia is important for monitoring and managing stomach health.
Causes & Symptoms
Clinical Causes: Chronic Helicobacter pylori infection Long-term inflammation of the stomach lining (gastritis) Diet high in smoked, salted, or poorly preserved foods Lifestyle factors such as smoking and excessive alcohol consumption Autoimmune disorders affecting the stomach Genetic predisposition and family history
Key Symptoms: Indigestion or stomach discomfort Bloating or feeling of fullness after meals Nausea or occasional vomiting Unintentional weight loss in advanced cases Occasional loss of appetite No symptoms in some individuals, making diagnosis incidental during endoscopy
Diagnostic & Treatment
Diagnosis Path: Gastric intestinal metaplasia is typically diagnosed through upper gastrointestinal endoscopy, where a doctor visually examines the stomach lining. During this procedure, a small tissue sample (biopsy) is taken and examined under a microscope. The biopsy confirms the presence of intestinal metaplasia. Additional tests such as blood tests for anemia or Helicobacter pylori infection may be performed to assess underlying causes or complications.
Treatment Protocols: There is no specific medical treatment for gastric intestinal metaplasia itself. Management strategies focus on monitoring and addressing underlying causes to reduce progression risk, including: - Eradication of Helicobacter pylori infection if present - Lifestyle modifications such as quitting smoking, reducing alcohol intake, and adopting a healthy diet - Regular follow-up endoscopies to observe for any changes or progression - Addressing any associated conditions like gastritis In cases where dysplasia (pre-cancerous changes) is identified, more aggressive interventions may be recommended. It is essential to consult healthcare providers for individualized management plans.
Clinical Advice & FAQs
Billing Guidance
Is K31.A0 a billable ICD-10 code?
Yes, K31.A0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report K31.A0?
Clinical documentation must specify the nature of Gastric intestinal metaplasia, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference